MYOCHRYSINE
SANOFI-AVENTIS CANADA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is MYOCHRYSINE discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that MYOCHRYSINE 25MG has been permanently discontinued (last updated June 10, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
SODIUM AUROTHIOMALATE INJECTION BP
SANDOZ CANADA INCORPORATED
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
01927612
Strength
25MG
Dosage Form
SOLUTION
Route
INTRAMUSCULAR
Active Ingredient
GOLD SODIUM THIOMALATE
Tier
Unrated
Last Updated
2019-06-10
Reason for Shortage
Other (Please describe in comments)
Other Products from SANOFI-AVENTIS CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
10MCG · DIN 02464276
DIN 02464349
20MCG · DIN 02464284
100UNIT · DIN 02469901
100UNIT · DIN 02469898
100UNIT · DIN 02469871
0.58MG · DIN 02254506
500UNIT · DIN 02422913
2000UNIT · DIN 02422948
3000UNIT · DIN 02422956
1000UNIT · DIN 02422921
4000UNIT · DIN 02448157